[Systemic lupus erythematosus. Clinical, biological and immunological studies. (Report on 30 cases). II].
D000328:Adult; D000906:Antibodies / Q000032:analysis / Q000145:classification; D000974:Antibodies, Antinuclear; D000962:Antimalarials / Q000627:therapeutic use; D003165:Complement System Proteins; D004247:DNA; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006657:Histones; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D008297:Male; D009698:Nucleoproteins; D012217:Rheumatoid Factor
D000906:Antibodies; D000974:Antibodies, Antinuclear; D000962:Antimalarials; D005938:Glucocorticoids; D006657:Histones; D007166:Immunosuppressive Agents; D009698:Nucleoproteins; D003165:Complement System Proteins; D004247:DNA; D012217:Rheumatoid Factor
Le lupus érythémateux disséminé. Etude clinique, biologique et immunologique. (A propos de 30 cas). II.